245 related articles for article (PubMed ID: 24140546)
21. Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model.
Logie J; Ganesh AN; Aman AM; Al-Awar RS; Shoichet MS
Biomaterials; 2017 Apr; 123():39-47. PubMed ID: 28161682
[TBL] [Abstract][Full Text] [Related]
22. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
23. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
24. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
25. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis.
Kumar G; Sharma S; Shafiq N; Pandhi P; Khuller GK; Malhotra S
Drug Deliv; 2011 Jan; 18(1):65-73. PubMed ID: 20735202
[TBL] [Abstract][Full Text] [Related]
27. Human Serum Albumin Nanoparticles as a Novel Delivery System for Cabazitaxel.
Zhou G; Jin X; Zhu P; Yao JU; Zhang Y; Teng L; Lee RJ; Zhang X; Hong W
Anticancer Res; 2016 Apr; 36(4):1649-56. PubMed ID: 27069142
[TBL] [Abstract][Full Text] [Related]
28. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice.
Zhang XY; Qiao H; Ni JM; Shi YB; Qiang Y
Eur J Pharm Sci; 2013 Jun; 49(3):411-22. PubMed ID: 23624327
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules.
Torrecilla D; Lozano MV; Lallana E; Neissa JI; Novoa-Carballal R; Vidal A; Fernandez-Megia E; Torres D; Riguera R; Alonso MJ; Dominguez F
Eur J Pharm Biopharm; 2013 Apr; 83(3):330-7. PubMed ID: 23262164
[TBL] [Abstract][Full Text] [Related]
30. Preparation and biological evaluation of paclitaxel loaded biodegradable PCL/PEG nanoparticles for the treatment of human neuroendocrine pancreatic tumor in mice.
Dubey N; Shukla J; Hazari PP; Varshney R; Ganeshpurkar A; Mishra AK; Trivedi P; Bandopadhaya GP
Hell J Nucl Med; 2012; 15(1):9-15. PubMed ID: 22413106
[TBL] [Abstract][Full Text] [Related]
31. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors.
Khalid MN; Simard P; Hoarau D; Dragomir A; Leroux JC
Pharm Res; 2006 Apr; 23(4):752-8. PubMed ID: 16550475
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
33. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.
Allard E; Passirani C; Garcion E; Pigeon P; Vessières A; Jaouen G; Benoit JP
J Control Release; 2008 Sep; 130(2):146-53. PubMed ID: 18582507
[TBL] [Abstract][Full Text] [Related]
34. The anti-tumoral efficacy of a docetaxel-loaded liposomal drug delivery system modified with transferrin for ovarian cancer.
Yuan MQ; Zhu F; Lou JY; Yuan WM; Fu L; Liu S; Zhang ZZ; Liu CY; He Q
Drug Res (Stuttg); 2014 Apr; 64(4):195-202. PubMed ID: 24154938
[TBL] [Abstract][Full Text] [Related]
35. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
[TBL] [Abstract][Full Text] [Related]
36. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model.
Bernardi A; Braganhol E; Jäger E; Figueiró F; Edelweiss MI; Pohlmann AR; Guterres SS; Battastini AM
Cancer Lett; 2009 Aug; 281(1):53-63. PubMed ID: 19286307
[TBL] [Abstract][Full Text] [Related]
37. Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas.
Fang JH; Lai YH; Chiu TL; Chen YY; Hu SH; Chen SY
Adv Healthc Mater; 2014 Aug; 3(8):1250-60. PubMed ID: 24623647
[TBL] [Abstract][Full Text] [Related]
38. Applications of nanosystems to anticancer drug therapy (Part I. Nanogels, nanospheres, nanocapsules).
Talevi A; Gantner ME; Ruiz ME
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):83-98. PubMed ID: 23227942
[TBL] [Abstract][Full Text] [Related]
39. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
[TBL] [Abstract][Full Text] [Related]
40. Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities.
Wang Z; Ho PC
Small; 2010 Nov; 6(22):2576-83. PubMed ID: 20976704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
